Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 169

Results For "RET"

1729 News Found

QIAGEN receives U.S. FDA emergency use authorization to analyze over 30 samples per hour
Digitisation | August 10, 2021

QIAGEN receives U.S. FDA emergency use authorization to analyze over 30 samples per hour

QIAreach SARS-CoV-2 antigen test, developed in collaboration with Ellume, is easy to use and provides accurate and objective results in 2 to 15 minutes


Carbon-based non-toxic and reusable wrapper to increase shelf life of fruits
Sustainability | August 09, 2021

Carbon-based non-toxic and reusable wrapper to increase shelf life of fruits

This work has been published in the journal ‘ACS applied materials and interface’


India's doctor-population ratio to reach WHO benchmark soon: Dr Vinod Paul
Healthcare | August 09, 2021

India's doctor-population ratio to reach WHO benchmark soon: Dr Vinod Paul

By 2022, 150,000 primary health care centres would be in place in rural as well as urban areas


Centre releases Rs. 60 crore to states seeking grants to tackle the Sickle Cell Anaemia
Policy | August 09, 2021

Centre releases Rs. 60 crore to states seeking grants to tackle the Sickle Cell Anaemia

Sickle Cell Disease Support Corner developed to create a database of individuals with sickle cell disease


India’s gets its first bio-bank for heart failure research
Drug Approval | August 06, 2021

India’s gets its first bio-bank for heart failure research

Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology


Apollo Hospitals successfully implants MitraClip
Healthcare | August 05, 2021

Apollo Hospitals successfully implants MitraClip

MitraClip implants give a new lease of life for frail and elderly patients who cannot go in for conventional open-heart surgery


Dr Reddy’s relaunch Naproxen Sodium Tablets in the US
News | August 04, 2021

Dr Reddy’s relaunch Naproxen Sodium Tablets in the US

It is part of the company’s pain/analgesics portfolio of OTC products


Nureca Ltd PAT at Rs 36.19 crore in Q1FY22
Healthcare | August 03, 2021

Nureca Ltd PAT at Rs 36.19 crore in Q1FY22

Nureca Ltd has reported financial results for the period ended June 30, 2021.


NPPA monitors and caps prices of essential drugs: Mandaviya
Policy | August 03, 2021

NPPA monitors and caps prices of essential drugs: Mandaviya

NPPA has capped the trade margin for Oxygen Concentrators at 70% on Price to Distributor (PTD) level


NPPA caps prices on five medical devices effective July 20th 2021
Policy | August 03, 2021

NPPA caps prices on five medical devices effective July 20th 2021

The highest reduction in prices for Pulse Oximeters, Blood Pressure Monitoring Machine and Nebulizer has been reported by importers